Abstracts by key term: dementia
Demenz stellt eine wachsende globale Herausforderung für die öffentliche Gesundheit dar; die Zahl der Betroffenen wird bis 2030 auf 78 Millionen geschätzt. Mit der steigenden Lebenserwartung nimmt auch die sozioökonomische und gesundheitliche Belastung durch Demenz erheblich zu. Der Typ-2-Diabetes mellitus (T2DM) ist ein gut etablierter Risikofaktor und erhöht die Wahrscheinlichkeit, eine Demenz – einschließlich Alzheimer-Krankheit und vaskulärer Demenz – zu entwickeln, um bis zu 60% [Biessels & Despa, 2018]. Die pathophysiologischen Mechanismen, die T2DM mit Demenz verbinden, umfassen chronische Hyperglykämie, Insulinresis-tenz, zerebrovaskuläre Dysfunktion, Neuroinflammation und oxidativen Stress – alles Faktoren, die zum kognitiven Abbau beitragen [Beeri & Bendlin, 2020]. Trotz intensiver Forschung existieren bislang keine krankheitsmodifizierenden Therapien für Demenz, was die Notwendigkeit unterstreicht, modifizierbare Risikofaktoren sowie pharmakologische Strategien zur Verlangsamung des kognitiven Abbaus zu identifizieren [Livingston et al., 2020].
30.11.2025
Healthy people swallow up to 2,000 times a day without even thinking about it. Aging processes jeopardize the adequacy of swallowing: Swallowing disorders in nursing homes are underdiagnosed, their impact underestimated, yet, along with their complications, they are the most common cause of death there. A closer look reveals a devastating picture of care. This paper outlines the current challenges of data inaccuracy and the lack of diagnostic and therapeutic care against the backdrop of possible innovative forms of care and their implementation in a care pathway yet to be developed.
03.12.2024
Previous studies have reported increased in-hospital mortality in patients with dementia (PwD), but findings across age groups, clinical departments, and admission diagnoses have been limited. The aim of this study is to compare in-hospital mortality in PwD across age groups, clinical departments, and admission diagnoses with that of control subjects without dementia.
03.12.2024
Commentary by Dipl.-Soz. Maren Ewald BA, Director StattHaus Offenbach, Hans and Ilse Breuer Foundation
03.06.2024
At the beginning of 2020, the "Interdisciplinary discussion forum on ethical, economic and medical challenges before the onset of dementia" was established in order to establish the public discussion on fundamental topics regarding diagnostics, therapy and care of dementia patients, which show a concrete need for action. found together. Current developments in the therapeutic field are discussed as well as ethical problems, gaps in care and special topics such as the use of biomarkers for risk stratification of patients in the early diagnosis of Alzheimer's disease.
05.06.2023
The invisible people responsible: relatives in reporting on dementia
Dementia is a challenge for society as a whole, and nursing care in particular is a major task. People with dementia are often cared for at home, the professional care situation in Germany is tense - relatives are often involved in the care themselves or care for them alone, which means a high level of physical and psychological stress.
04.02.2023
Using the example of dementia-related illnesses, the Barmer-GEK Care Report 2010 implicitly shows an essential dilemma in health services research: On the one hand, the diverse interdependencies between care and dementia are very well illuminated, and on the other hand, the broader connections between medicine, care and dementia can be presented, but on the other hand The presentation is only of limited use because billing data from outpatient and statutory health care is becoming less and less useful for making statements about the quality of care. This is becoming an increasing challenge for health insurance companies and the health system: How can the performance data from outpatient and statutory health care be meaningfully used for health services research?
23.09.2012
Like many others - especially Western countries - the demographic age structure of the Federal Republic of Germany will change significantly in the next few years. According to the Federal Statistical Office (2006: 23), the number of people aged 65 to under 80 will increase from 12 million in 2005 to 13 million in 2050. At the same time, the number of older and very old people in society will also increase of people in need of care. This means that the question of supply requirements and needs is increasingly coming to the fore. Particular attention must be paid to the care of people with dementia (PwD), since dementia-related diseases are among the most serious and numerically most common diseases in old age and the prevalence of dementia-related diseases increases significantly with increasing age (Weyerer 2005: 7). It is currently estimated that there will be more than two million people with dementia in Germany by the year 2050 (Ziegler/Doblhammer 2009; German Alzheimer Society 2008; Bickel 2001; Bickel 2000). According to a press release from the Federal Statistical Office, the medical costs for dementia in Germany in 2008 were estimated at 9.4 billion euros. “In the case of dementia and depression alone, the costs increased during this period [from 2002 to 2008] by a total of 3.5 billion euros or 32 billion euros. Overall, medical costs have increased by 35.5 billion euros since 2002 (+ 16 %) and amounted to 254.3 billion euros in 2008.” (Federal Statistical Office 2010).
24.02.2012
The Challenge of Dementia – Developing Care Structures for the Future According to Benjamin Gompertz's (1779-1865) law, a person's age increases linearly. However, the probability of developing a chronic illness, becoming dependent on care, or developing dementia increases exponentially over the course of life [Gompertz, 1825]. In our aging society, dealing with [...]
01.02.2010
Demographic change with an increase in the number of very old people, increasing public knowledge about dementia and increasing expectations of medical interventions from relatives and those affected will increase the demand for options for early diagnosis and therapy for memory impairments in old age. While currently a documented diagnosis only occurs in the 3rd year of dementia due to stigmatization, in the future an earlier diagnosis will probably occur in the 1st and 2nd year of the disease. In contrast to extensive further developments in the field of diagnostics, the therapeutic options are still limited. The increasing norm of living alone will often jeopardize the goal often expressed by older people of being able to provide care in their own home when dementia occurs in the future.